Navigation Links
March of Dimes awards $250,000 prize to leaders in understanding embryonic development
Date:5/4/2008

HONOLULU, MAY 5, 2008 Two scientists who helped explain how embryos develop and form limbs, the brain, and other organs have been chosen to receive the 2008 March of Dimes Prize in Developmental Biology.

Philip A. Beachy, PhD, and Clifford J. Tabin, PhD will share the 2008 March of Dimes Prize for their pioneering work that has expanded our understanding of how hedgehog genes and their protein signals guide the formation of the brain, limbs, spinal cord, axial skeleton and other organs during embryonic and fetal development. Their work has become a model for how communication between cells directs the course of animal development.

The March of Dimes Prize is a $250,000 cash award and a silver medal in the design of the Roosevelt dime, in honor of President Franklin Delano Roosevelt, who founded the March of Dimes. The Prize will be awarded to Dr. Beachy and Dr. Tabin at a gala black tie dinner and ceremony at the Moana Surfrider here.

Hedgehog genes have a wide-ranging role in mammalian development, said Michael Katz, MD, senior vice president for Research and Global Programs at the March of Dimes. Dr. Beachys and Dr. Tabins studies have provided crucial insight into how some birth defects and some cancers develop. The results of their research have expanded our knowledge of how these genes control the division of adult stem cells.

The genes are named hedgehog because when mutations that caused the gene to lose function first were identified (in fruit flies), they gave the embryos a prickly appearance. The genes protein signals play a crucial role in how cells organize themselves in the body and form specific organs.

For example, these signals are involved in why the heart is located on the left and not the right side of the body; why we have two eyes and nostrils instead of one; why the thumb is different from the little finger; and why different types of neurons form in specific locations within the spina
'/>"/>

Contact: Elizabeth Lynch
elynch@marchofdimes.com
914-997-4286
March of Dimes Foundation
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Top Music Artists Contribute to New CD for Moms to Benefit March of Dimes
2. Young Innovations, Inc. Announces Results for the Quarter Ended March 31, 2008
3. March for Babies a Success With Help From Equal Health
4. Eli Manning Leads March for Babies in Manhattan
5. Northwest Songwriter Dean Backholm Featured on National March of Dimes CD
6. Longs Reports Preliminary March Retail Drug Store Sales
7. Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the First Quarter Ended March 31, 2008
8. BioForm Medical to Announce Financial Results For Quarter Ended March 31, 2008, Third Quarter of Fiscal 2008, and Host Conference Call and Webcast on May 1, 2008
9. National Council on Disability Monthly Bulletin for March 2008
10. Humboldt Storage & Moving to Partner with March for Babies
11. March For Babies Has Celebrity Support -- Now It Needs Yours
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...ican women using Carraguard had no decrease in inf...4 (HealthDay News) -- A microbicidal vaginal gel c...fection. , That,s the conclusion of a study tha...gative women at three sites in South Africa. , ...o gel and told to use one applicator of gel and a ...
(Date:12/4/2008)..., Dec. 4 Aurora Health Care is ram... D supplements. Aurora,s Care Management,Clinical...ucate all Aurora,caregivers about the benefits of...g evidence that higher Vitamin D levels may improv...porosis, certain muscle conditions and,seasonal d...
(Date:12/4/2008)...N, Dec. 4 The U.S. Gove...Development (USAID), is providing an additional $6...abwe. This assistance is in addition to the $4 mi...gram USAID is already implementing in Zimbabwe. ,... working alongside the international community to ...
(Date:12/4/2008)...cts similar to those seen with standard dose of da...c. 4 (HealthDay News) -- A high dose of the chemot...tients with previously untreated acute myeloid leu...red by the U.S. National Cancer Institute (NCI) sh...row. This study included 633 patients, aged 16 to ...
Breaking Medicine News(10 mins):Health News:Experimental Vaginal Gel Doesn't Ward Off HIV 2Health News:Aurora Health Care Urges All Wisconsin Residents to Take Vitamin D 2Health News:USAID Increases Assistance for Zimbabwe Cholera Outbreak 2Health News:Higher Chemo Drug Dose Prolongs Lives of Leukemia Patients 2
...ming at getting the children in northern communiti...h Promotion Minister, Jim Watson, the government w... carrot sticks, apples and other fresh fruit and v... children in elementary schools in Northern Ontari...
... found to have a role in the treatment of lung dis...cent research. // The results of the study have b...and Journal of Medicine, which has revealed that t...tment of cancer could slightly improve lung functi...
...o a vasectomy reversal could be at an increased ri...ead to birth defects in children. // The research...ersity, Bangkok, Thailand. The study was conducted...rocedure which does not interfere with sperm produ...
...daily doses of insulin injections. However in peop...f the pancreatic tissue// could help solve the pro...lindness, amputation, kidney failure, and heart di...early enough organ donors available for transplant...
Other Medicine News:Health News:Obesity Tackled at School Level 2Health News:Cancer Drug to Treat Scleroderma Lung Disease 2Health News:Vasectomy Reversal to Lead to Birth Defects 2Health News:Transplanted Pancreatic Tissue Could Help Diabetics 2
(Date:12/2/2008)...ratories, a leading clinical-diagnostics and biom...ogy and allergy assays, announced that it has laun...nts whose immune systems may be compromised due to... drugs, or because they are taking immuno-suppress...e company launched the two new assays, the T Cell...
(Date:12/2/2008)...Therapeutics, Inc., a,privately held biopharmaceu...hase 3 trials evaluating its lead investigational ...ints. HZT-501, a novel, proprietary fixed-dose,co...ine, demonstrated a,statistically significant red...lammatory drug (NSAID)-induced upper gastrointesti...
(Date:12/1/2008)...w research has found that the availability of a po...r in an emergency room can significantly increase ...ally life-saving treatment. Results of the study, ...em Hospital in Salem, Mass., will be presented tod...ty of North America (RSNA). , , "The hospit...
(Date:12/1/2008)... -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA ) r...ld,s leading medical journals, results of clinical...ntal compound tasimelteon (VEC-162). The publicat...agonist tasimelteon (VEC-162) for transient insomn...ed multicentre trials." Results are reported from ...
Breaking Medicine Technology:IBT Laboratories Expands its Menu of Tests for Immune Deficiency 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Portable CT Increases Chance of Stroke Survival and Recovery 2Portable CT Increases Chance of Stroke Survival and Recovery 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 2Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 3Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet 4Caregivers Protest Statewide to Stop Daughters of Charity From Silencing the Voice of Caregivers 26 Threatening Patient Care 23128 1Caregivers Protest Statewide to Stop Daughters of Charity From Silencing the Voice of Caregivers 26 Threatening Patient Care 23128 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and 248 3 Million Financing 6353 1Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and 248 3 Million Financing 6353 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and 248 3 Million Financing 6353 3Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and 248 3 Million Financing 6353 4SXC Health Solutions announces informedRx renewal contract with The University of Michigan 23122 1SXC Health Solutions announces informedRx renewal contract with The University of Michigan 23122 2Breastfeeding com Launches First Ever Social Network for Birth Related Medical Professionals 23118 1Breastfeeding com Launches First Ever Social Network for Birth Related Medical Professionals 23118 2
...IDGE, Mass., July 06, 2007 /PRNewswire-FirstCall/ ...m the first of two,Phase 3 clinical studies to ass...n investigational, non-antibiotic, polymer,therapy...d diarrhea,(CDAD). The second Phase 3 study of tol...pected later this year. , In this first Phase 3 st...
..., Switzerland--(BUSINESS WIRE)--Jul 9, 2007 - ZIOP...positive interim data,from an ongoing phase II tri...treat advanced sarcoma patients was presented at t...ting held July 5-8,2007 in Lugano, Switzerland. T...O-201) In Advanced Sarcoma," was presented by,Rash...
Other Medicine Technology:Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 2Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 3Genzyme Announces Data from First Phase 3 Study of Tolevamer in,Patients with C. difficile Associated Diarrhea 4Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 2Positive ZIO-201 Interim Phase II Sarcoma Data Presented at,European Society for Medical Oncology 3
The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems.
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem.
The Natural-Hip combines the surgical simplicity of a straight stem with many of the best features of an anatomic stem.
The standard of proximal press-fit design. The CLS hip is a straight stem design that is available in 13 sizes in two different neck angles, 135 and 145, to accommodate a wide variety of patient anat
Medicine Products: